phase 1_initiation
saveNanjing IASO Biotherapeutics Co Ltd — IASO-782 (Phase I Trial Initiation)
community read0 votes
Therapy area: Immunology. Indication: Systemic Lupus Erythematosus
Therapy area: Immunology. Indication: Systemic Lupus Erythematosus